Bausch Health Companies Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Bausch Health Companies Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2020 to Q3 2024.
  • Bausch Health Companies Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$85M, a 77.5% increase year-over-year.
  • Bausch Health Companies Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$178M, a 81.5% increase year-over-year.
  • Bausch Health Companies Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$592M, a 163% decline from 2022.
  • Bausch Health Companies Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$225M, a 76.3% increase from 2021.
  • Bausch Health Companies Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$948M, a 69.3% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$178M -$85M +$293M +77.5% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-31
Q2 2024 -$471M $10M -$16M -61.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 -$455M -$64M +$137M +68.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 -$592M -$39M +$371M +90.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-22
Q3 2023 -$963M -$378M -$777M -195% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-31
Q2 2023 -$186M $26M +$171M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 -$357M -$201M -$132M -191% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 -$225M -$410M -$479M -694% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-22
Q3 2022 $254M $399M +$211M +112% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $43M -$145M +$450M +75.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 -$407M -$69M +$541M +88.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 -$948M $69M +$222M Oct 1, 2021 Dec 31, 2021 10-K 2024-02-22
Q3 2021 -$1.17B $188M +$117M +165% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$1.29B -$595M -$269M -82.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$1.02B -$610M -$458M -301% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 -$560M -$153M Oct 1, 2020 Dec 31, 2020 10-K 2023-02-23
Q3 2020 $71M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 -$326M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 -$152M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.